99 related articles for article (PubMed ID: 1375799)
21. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
[TBL] [Abstract][Full Text] [Related]
22. [Recent etiopathogenetic and therapeutic acquisitions in acute hemorrhagic pancreatitis].
Ardiacono R; Porati M; Sanna G
Recenti Prog Med; 1969 Feb; 46(2):21-3. PubMed ID: 5306182
[No Abstract] [Full Text] [Related]
23. [Anti-oxidative therapy of pancreatitis--an 18-month interim evaluation].
Kuklinski B; Buchner M; Müller T; Schweder R
Z Gesamte Inn Med; 1992 Jun; 47(6):239-45. PubMed ID: 1642022
[TBL] [Abstract][Full Text] [Related]
24. [Trasylol in clinical pancreatitis].
Grözinger KH
Langenbecks Arch Chir; 1969; 325():343-7. PubMed ID: 5309036
[No Abstract] [Full Text] [Related]
25. Oxidative stress in acute pancreatitis.
Schulz HU; Niederau C; Klonowski-Stumpe H; Halangk W; Luthen R; Lippert H
Hepatogastroenterology; 1999; 46(29):2736-50. PubMed ID: 10576339
[TBL] [Abstract][Full Text] [Related]
26. [Effect of antioxidants on the course of experimental pancreatitis].
Vlasov AP; Trofimov VA; Misharin IV; Vlasova VP; Tsilikina OV; Keleĭnikov AB; Atamankin IV
Eksp Klin Farmakol; 2007; 70(3):25-8. PubMed ID: 17650628
[TBL] [Abstract][Full Text] [Related]
27. [When do proteinase inhibitors improve acute pancreatitis?].
Mättig H
Zentralbl Chir; 1970 Sep; 95(39):1142-9. PubMed ID: 5311844
[No Abstract] [Full Text] [Related]
28. [Clinical and experimental principles of anti-enzyme therapy].
Silva Pozo J; Ortiz Vázquez J; Pascual Marcos S; Pérez de Lema JA; Segura Sánchez A
Rev Clin Esp; 1969 May; 113(3):209-24. PubMed ID: 4982835
[No Abstract] [Full Text] [Related]
29. Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats.
Yagci G; Gul H; Simsek A; Buyukdogan V; Onguru O; Zeybek N; Aydin A; Balkan M; Yildiz O; Sen D
J Gastroenterol; 2004; 39(3):268-76. PubMed ID: 15065005
[TBL] [Abstract][Full Text] [Related]
30. [Clinical trial with Trasylol against acute pancreatitis].
Möller C; Stjernvall L
Ann Chir Gynaecol Fenn; 1969; 58(4):296-9. PubMed ID: 4908936
[No Abstract] [Full Text] [Related]
31. [Acute postoperative pancreatitis].
Kulazhenkov SA; Anisimov MA; Fëdorov VN; Kuznetsov EV
Khirurgiia (Mosk); 1994 Jan; (1):6-10. PubMed ID: 8176882
[TBL] [Abstract][Full Text] [Related]
32. Recalcitrant pancreatitis: eventual control by antioxidants.
Braganza JM; Jeffrey IJ; Foster J; McCloy RF
Pancreas; 1987; 2(4):489-94. PubMed ID: 3628241
[TBL] [Abstract][Full Text] [Related]
33. [Viruses and oxidative stress].
Weismann H
Dtsch Med Wochenschr; 1996 May; 121(21):A8. PubMed ID: 8646971
[No Abstract] [Full Text] [Related]
34. [When is the use of kallikrein inhibitors indicated in the therapy of acute pancreatitis?].
Trapnell JE
Med Welt; 1980 Aug; 31(33):1174-9. PubMed ID: 6158646
[No Abstract] [Full Text] [Related]
35. Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds.
Vermeulen NP; Baldew GS; Los G; McVie JG; De Goeij JJ
Drug Metab Dispos; 1993; 21(1):30-6. PubMed ID: 8095223
[TBL] [Abstract][Full Text] [Related]
36. [The therapy of acute pancreatitis with Trasylol].
Gesztesi T; Füredi L
Z Arztl Fortbild (Jena); 1966 Sep; 60(18):1061-7. PubMed ID: 5300866
[No Abstract] [Full Text] [Related]
37. Malondialdehyde and superoxide dismutase as potential markers of severity in acute pancreatitis.
Abu-Hilal M; McPhail MJ; Marchand L; Johnson CD
JOP; 2006 Mar; 7(2):185-92. PubMed ID: 16525202
[TBL] [Abstract][Full Text] [Related]
38. [Effectiveness of the use of trasylol in the complex therapy of patients with acute and chronic recurrent pancreatitis].
Asauliuk IK
Vrach Delo; 1967 Oct; 10():14-6. PubMed ID: 5306817
[No Abstract] [Full Text] [Related]
39. [Selenium substitution after cardiac arrest].
Busch HJ
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 11():S419-21. PubMed ID: 19998235
[No Abstract] [Full Text] [Related]
40. Effects of selenium supplementation on malignant lymphoproliferative pathologies associated with OF1 mouse ageing.
Wong HK; Riondel J; Ducros V; Ballester B; Mathieu J; Favier A
Anticancer Res; 2001; 21(1A):393-402. PubMed ID: 11299768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
